Progression to PD-1 Antibody
1 clinical trials · Condition
◉ Watch Progression to PD-1 Antibody
| Record | Firm | Date |
|---|---|---|
| An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 Antibody (NCT04866381) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-01 |
Track Progression to PD-1 Antibody automatically
Every clearance here is in the API, with alerts when new ones post.